Ty E. Dedmon

Ty Dedmon is a partner in the Litigation Practice Group. His practice focuses on the areas of Life Sciences and Commercial litigation. His representation of life sciences clients in both commercial and personal injury disputes gives him a unique perspective in assisting many of the firm’s clients in all aspects of the healthcare industry. His commercial litigation experience includes the representation of clients in the transportation and logistics industry, as well as an online travel company involved in dozens of hotel occupancy tax disputes nationwide.Ty’s life sciences practice includes defending toxic tort and medical malpractice claims, and as well as mass torts involving the pharmaceutical industry. Ty regularly represents physicians, nurses, and hospitals in medically complex professional liability actions and has overseen discovery efforts in several sets of mass tort litigation involving prescription and over-the-counter medications. Ty was part of a trial team defending Monsanto Company against several thousand personal injury claims related to alleged exposure to PCBs that resulted in a defense verdict.Ty also represents healthcare clients in various commercial litigation areas, including defense of pharmaceutical manufacturers against AWP pricing fraud claims by Alabama Medicaid, as well as defending healthcare and construction clients against qui tam actions under the False Claims Act. In addition, Ty was heavily involved in the defense of a high profile claim by the Centers for Medicare Services under the Medicare Secondary Payer Act, in which the government sought nearly $200 million in Medicare repayments from a chemical company that had previously made settlement payments to Medicare beneficiaries in a mass tort action. The Eleventh Circuit recently upheld the dismissal of these claims.Ty also regularly representing transportation and logistics industry clients in administrative proceedings, cargo claims, motor vehicle accidents, and contract disputes, as well as other business tort actions. Ty also has significant experience enforcing and defending non-compete and non-disclosure agreements in several different industries.Ty’s work on behalf of an online travel company engaged in over forty active hotel occupancy tax disputes across the country, as well as his experience overseeing discovery in a variety of mass product liability actions, has given him significant experience in the management of e-discovery issues. He currently leads the firm’s e-discovery task force, and regularly advises on e-discovery solutions.

Ty Dedmon is a partner in the Litigation Practice Group. His practice focuses on the areas of Life Sciences and Commercial litigation. His representation of life sciences clients in both commercial and personal injury disputes gives him a unique perspective in assisting many of the firm’s clients in all aspects of the healthcare industry. His commercial litigation experience includes the representation of clients in the transportation and logistics industry, as well as an online travel company involved in dozens of hotel occupancy tax disputes nationwide.Ty’s life sciences practice includes defending toxic tort and medical malpractice claims, and as well as mass torts involving the pharmaceutical industry. Ty regularly represents physicians, nurses, and hospitals in medically complex professional liability actions and has overseen discovery efforts in several sets of mass tort litigation involving prescription and over-the-counter medications. Ty was part of a trial team defending Monsanto Company against several thousand personal injury claims related to alleged exposure to PCBs that resulted in a defense verdict.Ty also represents healthcare clients in various commercial litigation areas, including defense of pharmaceutical manufacturers against AWP pricing fraud claims by Alabama Medicaid, as well as defending healthcare and construction clients against qui tam actions under the False Claims Act. In addition, Ty was heavily involved in the defense of a high profile claim by the Centers for Medicare Services under the Medicare Secondary Payer Act, in which the government sought nearly $200 million in Medicare repayments from a chemical company that had previously made settlement payments to Medicare beneficiaries in a mass tort action. The Eleventh Circuit recently upheld the dismissal of these claims.Ty also regularly representing transportation and logistics industry clients in administrative proceedings, cargo claims, motor vehicle accidents, and contract disputes, as well as other business tort actions. Ty also has significant experience enforcing and defending non-compete and non-disclosure agreements in several different industries.Ty’s work on behalf of an online travel company engaged in over forty active hotel occupancy tax disputes across the country, as well as his experience overseeing discovery in a variety of mass product liability actions, has given him significant experience in the management of e-discovery issues. He currently leads the firm’s e-discovery task force, and regularly advises on e-discovery solutions.

Ty Dedmon is a partner in the Litigation Practice Group. His practice focuses on the areas of Life Sciences and Commercial litigation. His representation of life sciences clients in both commercial and personal injury disputes gives him a unique perspective in assisting many of the firm’s clients in all aspects of the healthcare industry. His commercial litigation experience includes the representation of clients in the transportation and logistics industry, as well as an online travel company involved in dozens of hotel occupancy tax disputes nationwide.

Ty’s life sciences practice includes defending toxic tort and medical malpractice claims, and as well as mass torts involving the pharmaceutical industry. Ty regularly represents physicians, nurses, and hospitals in medically complex professional liability actions and has overseen discovery efforts in several sets of mass tort litigation involving prescription and over-the-counter medications. Ty was part of a trial team defending Monsanto Company against several thousand personal injury claims related to alleged exposure to PCBs that resulted in a defense verdict.

Ty also represents healthcare clients in various commercial litigation areas, including defense of pharmaceutical manufacturers against AWP pricing fraud claims by Alabama Medicaid, as well as defending healthcare and construction clients against qui tam actions under the False Claims Act. In addition, Ty was heavily involved in the defense of a high profile claim by the Centers for Medicare Services under the Medicare Secondary Payer Act, in which the government sought nearly $200 million in Medicare repayments from a chemical company that had previously made settlement payments to Medicare beneficiaries in a mass tort action. The Eleventh Circuit recently upheld the dismissal of these claims.

Ty also regularly representing transportation and logistics industry clients in administrative proceedings, cargo claims, motor vehicle accidents, and contract disputes, as well as other business tort actions. Ty also has significant experience enforcing and defending non-compete and non-disclosure agreements in several different industries.

Ty’s work on behalf of an online travel company engaged in over forty active hotel occupancy tax disputes across the country, as well as his experience overseeing discovery in a variety of mass product liability actions, has given him significant experience in the management of e-discovery issues. He currently leads the firm’s e-discovery task force, and regularly advises on e-discovery solutions.